A Stanford physician co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.
Abdominal adhesions frequently occur after abdominal surgery. Stanford researchers prevented their formation in mice by blocking a molecular pathway.
A device to prevent falls and another to better diagnose people with developmental disorders are among the AI projects funded under a new grant program.
A Stanford-led study finds that remnants of an ancient viral infection may be the reason humans and other primates evolved to have larger hearts and bodies.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
A Stanford dermatologist weighs in on using retinol to fight aging, acne and other skin problems, and whether it deserves the hype.
A Stanford research team is tasked with assessing the COVID-19 infection crisis inside California’s prisons and providing strategies to contain the virus.
Stanford researchers have shown how to create wireless brain-computer interfaces that could enable amputees to operate thought-controlled prostheses.
Friends and colleagues, Stanford nephrology fellows Daniel Watford and Dimitri Augustin trained alongside each other in Florida and then both moved west.
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
Stanford postdoc Brielle Ferguson helped to organize a project called 'Black in Neuro Week' to amplify Black scientists in neuroscience.
After treating a patient with an unusual ammonia metabolism problem, a Stanford researcher assembled a team to reimagine ammonia blood testing.
Stanford-led research finds that the blood-brain barrier may be much more permeable -- albeit selectively so -- than previously thought.
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.
Stanford scientists have devised a way to use positron emission tomography to watch the movement of a single cell injected into a lab mouse in real time.
